Bayer Cropscience Ltd.

NSE: BAYERCROP | BSE: 506285 | ISIN: INE462A01022 | Industry: Agrochemicals
| Expensive Performer
5617.5000 -37.00 (-0.65%)
NSE Jun 18, 2025 13:40 PM
Volume: 11,244
 

5617.50
-0.65%
Karvy
Increasing proportion of manufactured goods in the overall revenue from 43%in FY15 to 44% in FY17E is expected to lead to a 20 basis points jump in grossmargins from 64.8% in FY15 to 65.0% in FY16E & FY17E. It could have been higher, if not for the weak macro-industry environment. This increase is expected to act as a cushion for the EBITDA margins going forward. But, significant dependence on traded goods will continue to act as a ceiling for margins. We expect EBITDA margins to remain stable at lower levels of 11.9% & 12.3% in FY16E & FY17E respectively.
Number of FII/FPI investors decreased from 208 to 198 in Mar 2025 qtr
More from Bayer Cropscience Ltd.
Recommended